Myosin heavy chain is stabilized by BCL-2 interacting cell death suppressor (BIS) in skeletal muscle
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Jin | - |
dc.contributor.author | Park, Jun-Sub | - |
dc.contributor.author | Lee, Hyun | - |
dc.contributor.author | Jeong, Jaemin | - |
dc.contributor.author | Yun, Hye Hyeon | - |
dc.contributor.author | Kim, Hye Yun | - |
dc.contributor.author | Ko, Young-Gyu | - |
dc.contributor.author | Lee, Jeong-Hwa | - |
dc.date.accessioned | 2021-09-04T00:51:01Z | - |
dc.date.available | 2021-09-04T00:51:01Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016-04 | - |
dc.identifier.issn | 1226-3613 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/88966 | - |
dc.description.abstract | BCL-2 interacting cell death suppressor (BIS), which is ubiquitously expressed, has important roles in various cellular processes, such as apoptosis, the cellular stress response, migration and invasion and protein quality control. In particular, BIS is highly expressed in skeletal and cardiac muscles, and BIS gene mutations result in human myopathy. In this study, we show that mRNA and protein levels of BIS were markedly increased during skeletal myogenesis in C2C12 cells and mouse satellite cells. BIS knockdown did not prevent the early stage of skeletal myogenesis, but did induce muscle atrophy and a decrease in the diameter of myotubes. BIS knockdown significantly suppressed the expression level of myosin heavy chain (MyHC) without changing the expression levels of myogenic marker proteins, such as Mgn, Cav-3 and MG53. In addition, BIS endogenously interacted with MyHC, and BIS knockdown induced MyHC ubiquitination and degradation. From these data, we conclude that molecular association of MyHC and BIS is necessary for MyHC stabilization in skeletal muscle. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.subject | MYOFIBRILLAR MYOPATHIES | - |
dc.subject | EARLY LETHALITY | - |
dc.subject | BAG3 | - |
dc.subject | PROTEIN | - |
dc.subject | MYOGENESIS | - |
dc.subject | MUTATION | - |
dc.subject | MACROAUTOPHAGY | - |
dc.subject | AUTOPHAGY | - |
dc.subject | ADHESION | - |
dc.subject | STRESS | - |
dc.title | Myosin heavy chain is stabilized by BCL-2 interacting cell death suppressor (BIS) in skeletal muscle | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ko, Young-Gyu | - |
dc.identifier.doi | 10.1038/emm.2016.2 | - |
dc.identifier.wosid | 000375703400002 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL AND MOLECULAR MEDICINE, v.48 | - |
dc.relation.isPartOf | EXPERIMENTAL AND MOLECULAR MEDICINE | - |
dc.citation.title | EXPERIMENTAL AND MOLECULAR MEDICINE | - |
dc.citation.volume | 48 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002102743 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | MYOFIBRILLAR MYOPATHIES | - |
dc.subject.keywordPlus | EARLY LETHALITY | - |
dc.subject.keywordPlus | BAG3 | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | MYOGENESIS | - |
dc.subject.keywordPlus | MUTATION | - |
dc.subject.keywordPlus | MACROAUTOPHAGY | - |
dc.subject.keywordPlus | AUTOPHAGY | - |
dc.subject.keywordPlus | ADHESION | - |
dc.subject.keywordPlus | STRESS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.